Rubius Therapeutics Outlines Dissolution Plan, After Unsuccessful Attempt On Alternatives
In November 2022, Rubius Therapeutics Inc (NASDAQ: RUBY) initiated a process to explore a range of strategic alternatives and planned to engage an investment bank to act as a strategic advisor. But the battered company failed to find any alternatives, and the company's board approved a plan of liqu...